IP Library Granted Patent US 9,125,950
Granted Patent B2
US 9,125,950 · App. 14/486,504 · Granted Sep 8, 2015

Siderophore conjugate immunogenic compositions and vaccines

Inventor: Raymond J. Bergeron, Jr. (Gainesville, FL)
Assignee: University of Florida Research Foundation, Inc.
A61K47/48276A61K39/107A61K39/385A61K47/4833A61K47/48284C07K16/1239A61K2039/6031A61K2039/6068A61K2039/6081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,125,950
App. No.
14/486,504
Granted
Sep 8, 2015
Kind
B2
Abstract

An immunogenic composition comprising a siderophore covalently linked to a pharmaceutically acceptable carrier molecule wherein the antigenicity of the siderophore moiety is sufficient to stimulate an immunologic response to the siderophore when the composition is circulating in the bloodstream of a human or non-human animal and vaccine.

Claims (13)

1. A method for inducing an immune response in a human or non-human animal against a strain of Vibrio , comprising administering to the animal an immunogenic composition comprising a conjugate, wherein the conjugate comprises a siderophore covalently linked to a pharmaceutically acceptable carrier molecule, wherein:

the siderophore is vibriobactin or vulnibactin;

the pharmaceutically acceptable carrier molecule comprises a protein; and

the antigenicity of the conjugate is sufficient to stimulate an immunologic response to said conjugate when said conjugate is circulating in the bloodstream of the animal.

2. The method of claim 1 , wherein said immunologic response comprises the production of antibodies to at least one outer membrane siderophore receptor, outer membrane siderophore receptor-siderophore complex, or outer membrane siderophore receptor-ferrisiderophore complex of Vibrio cholerae.

3. The method of claim 1 , wherein the siderophore is vibriobactin.

4. The method of claim 1 , wherein the siderophore is vulnibactin.

5. The method of claim 1 , wherein said protein comprises a vibriobactin receptor protein.

6. The method of claim 5 , wherein the vibriobactin receptor protein is a vibriobactin receptor protein of Vibrio cholerae.

7. The method of claim 1 , wherein said protein comprises a vulnibactin receptor protein.

8. The method of claim 1 , wherein said protein comprises bovine serum albumin (BSA) or ovalbumin (OVA).

9. The method of claim 1 , wherein the immunogenic composition further comprises a pharmaceutically acceptable excipient.

10. The method of claim 1 wherein the Vibrio species is Vibrio cholerae excipient.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 7, 2016
From: UNIVERSITY OF FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040569/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2014
From: BERGERON, RAYMOND J., JR.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 034519/0656 →
Continuity (3)
Division 13265651
Provisional Application 61171151 · Apr 21, 2009
Related Publication 20150071961A1 · Mar 12, 2015